Headlines- After talks in Washington on Tuesday that US Secretary of State Marco Rubio described as a "historic opportunity" for peace, Israel and Lebanon agreed to hold direct talks.
- Iran talks could resume "over the next two days," according to US President Donald Trump, after the failure of last weekend's first round in Pakistan.
- Six merchant ships turned around after "direction from US forces," according to the US, and no ships were able to pass through the blockade in the first 24 hours.
- According to the Lebanese Ministry of Public Health, there were at least 35 deaths and 159 injuries in Lebanon on Tuesday.
- The southern Lebanon district of Bint Jbeil has been hit by an Israeli airstrike.
- "The short-term authorization permitting the sale of Iranian oil already stranded at sea is set to expire in a few days and will not be renewed," according to the US Treasury Department.
Tag: Malaria
Scientists Warn Urgent Action Needed to...
In some parts of Africa, the primary treatment for malaria, artemisinin, is becoming less effective against the parasite that causes the disease. Without immediate changes in health policy, a new analysis warns that millions more deaths could occur.
Malaria Free VIllage in Malawi
Last year, Malawi had nearly seven million malaria cases, accounting for nearly a third of the population, with 2,500 people lost their lives as a result of the mosquito-borne diseases. However, one village has become a model for malaria eradication, and was recognised in June as the first to have zero malaria cases for a whole year
To Curb Malaria Burkina Faso Tests...
Malaria vaccines produced in Burkina Faso aren’t the only ones being tested in the country to combat the mosquito-borne disease. Scientists in the West African country have been breeding genetically engineered mosquitos with the aim of reducing mosquito populations’ ability to transmit malaria
Africa Malaria Vaccine
In an exclusive interview with VOA, the director of Oxford University’s Jenner Institute says their new malaria vaccine, tested in Burkina Faso, has shown a preliminary efficacy rate of 77%, which could help prevent over 400,000 deaths a year, most of them in sub-Saharan Africa